Nuclear pore complex proteins in Alzheimer disease

Journal of Neuropathology and Experimental Neurology

Volumn 65, Issue 1, 2006, Pages 45-54

  Sheffield, Lynette G ^a   Miskiewicz, Hayley B ^a   Tannenbaum, Lindsey B ^a   Mirra, Suzanne S ^a  

^a SUNY Downstate Medical Center   (United States)

Author keywords

Alzheimer disease; Apoptosis; Cell cycle; Neurofibrillary tangle; Nuclear pore complex; Nucleoporin

Indexed keywords

CARRIER PROTEIN; CASPASE 3; CELL CYCLE PROTEIN; CYCLIN B1; NUCLEAR TRANSPORT FACTOR 2; NUCLEOPORIN; NUCLEOPORIN 62; POLYCLONAL ANTIBODY; TAU PROTEIN; UNCLASSIFIED DRUG; CASP3 PROTEIN, HUMAN; CASP3 PROTEIN, RAT; CASPASE; NTF2 PROTEIN, RAT; NUCLEOCYTOPLASMIC TRANSPORT PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL NUCLEUS MEMBRANE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; NEOCORTEX; NEUROFIBRILLARY TANGLE; NICK END LABELING; NUCLEAR PORE COMPLEX; NUCLEOCYTOPLASMIC TRANSPORT; PAIRED HELICAL FILAMENT; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; BIOLOGICAL MODEL; BIOPSY; CELL COUNT; COMPARATIVE STUDY; FRONTAL LOBE; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; NERVE CELL; NUCLEAR PORE; PATHOLOGY; PATHOPHYSIOLOGY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ALZHEIMER DISEASE; BIOPSY; CASPASE 3; CASPASES; CELL COUNT; FRONTAL LOBE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, NEUROLOGICAL; NEUROFIBRILLARY TANGLES; NEURONS; NUCLEAR PORE; NUCLEAR PORE COMPLEX PROTEINS; NUCLEOCYTOPLASMIC TRANSPORT PROTEINS; TAU PROTEINS;

EID: 33644916708     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jnen.0000195939.40410.08     Document Type: Article

References (52)

1. Mirra SS, Wood JG, Pollock NJ, et al. New observations on the fine structure of Alzheimer's disease [Abstract]. J Neuropathol Exp Neurol 1987;46:377
2. Metuzals J, Robitaille Y, Houghton S, et al. Paired helical filaments and the cytoplasmic-nuclear interface in Alzheimer's disease. J Neurocytol 1988;17:827-33
3. Talcott B, Moore MS. Getting across the nuclear pore complex. Trends Cell Biol 1999;9:312-18
4. Cronshaw JM, Krutchinsky AN, Zhang W, et al. Proteomic analysis of the mammalian nuclear pore complex. J Cell Biol 2002;158:915-27
5. Fahrenkrog B, Aebi U. The nuclear pore complex: Nucleocytoplasmic transport and beyond. Nat Rev Molec Cell Biol 2003;4:757-66
6. Fried H, Kutay U. Nucleocytoplasmic transport: Taking an inventory. Cell Mol Life Sci 2003;60:1659-88
7. Cronshaw JM, Matunis MJ. The nuclear pore complex: Disease associations and functional correlations. Trends Endocrinol Metab 2004;15:34-39
8. Martínez N, Alonso A, Moragues MD, et al. The nuclear pore complex protein Nup88 is overexpressed in tumor cells. Cancer Res 1999;59:5408-11
9. Gould VE, Martinez N, Orucevic A, et al. A novel, nuclear pore-associated, widely distributed molecule overexpressed in oncogenesis and development. Am J Pathol 2000;157:1605-13
10. Gould VE, Orucevic A, Zentgraf N, et al. Nup88 (karyoporin) in human malignant neoplasms and dysplasias: Correlations of immunostaining of tissue sections, cytologic smears, and immunoblot analysis. Hum Pathol 2002;33:536-44
11. Kraemer D, Wozniak RW, Globel G, Radu A. The human CAN protein, a putative oncogene product associated with myeloid leukomogenesis, is a nuclear pore complex protein that faces the cytoplasm. Proc Natl Acad Sci U S A 1994;91:1519-23
12. Cronshaw JM, Matunis MJ. The nuclear pore complex protein ALADIN is mislocalized in triple A syndrome. Proc Natl Acad Sci U S A 2003;100:5823-27
13. Kimber J, McLean BN, Prevett M, Hammans SR. Allgrove or 4 'A' syndrome: An autosomal recessive syndrome causing multisystem neurological disease. J Neurol Neurosurg Psychiatry 2003;74:654-57
14. Jun L, Frints S, Duhamel H, et al. NXF5, a novel member of the nuclear RNA export factor family, is lost in a male patient with a syndromic form of mental retardation. Curr Biol 2001;11:1381-91
15. Falcieri E, Gobbi P, Cataldi A, et al. Nuclear pores in the apoptotic cell. Histochem J 1994;26:754-63
16. Buendia B, Santa-Maria A, Courvalin JC. Caspase-dependent proteolysis of integral and peripheral proteins of nuclear membranes and nuclear pore complex proteins during apoptosis. J Cell Sci 1999;112:1743-53
17. Kihlmark M, Imreh G, Hallberg E. Sequential degradation of proteins from the nuclear envelope during apoptosis. J Cell Sci 2001;114:3643-53
18. Yuan J, Yankner BA. Apoptosis in the nervous system. Nature 2000;407:802-9
19. Roth KA. Caspases, apoptosis, and Alzheimer disease: Causation, correlation, and confusion. J Neuropathol Exp Neurol 2001;60:829-38
20. Friedlander RM. Apoptosis and caspases in neurodegenerative diseases. N Engl J Med 2003;348:1365-75
21. Dickson DW. Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: Cause or effect? J Clin Invest 2004;114:23-27
22. Cotman CW, Poon WW, Rissman RA, Blurton-Jones M. The role of caspase cleavage of tau in Alzheimer disease neuropathology. J Neuropathol Exp Neurol 2005;64:104-12
23. Smale G, Nichols NR, Brady DR, et al. Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 1995;133:225-30
24. Kobayashi K, Nakano H, Hayashi M, et al. Association of phosphorylation site of tau protein with neuronal apoptosis in Alzheimer's disease. J Neurol Sci 2003;208:17-24
25. Gervais FG, Xu D, Robertson GS, et al. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-β precursor protein and amyloidogenic Aβ peptide formation. Cell. 1999;97:395-406
26. Selznick LA, Holtzman DM, Han BH, et al. In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease. J Neuropathol Exp Neurol 1999;58:1020-26
27. Ayala-Grosso C, Ng G, Roy S, Robertson GS. Caspase-cleaved amyloid precursor protein in Alzheimer's disease. Brain Pathol 2002;12:430-41
28. Rohn TT, Rissman RA, Davis MC, et al. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain. Neurobiol Dis 2002;11:341-54
29. Macaulay C, Forbes DJ. Assembly of the nuclear pore: Biochemically distinct steps revealed with NEM, GTPγS, and BAPTA. J Cell Biol 1996;132:5-20
30. Bodoor K, Shaikh S, Salina D, et al. Sequential recruitment of NPC proteins to the nuclear periphery at the end of mitosis. J Cell Sci 1999;112:2253-64
31. Suntharalingam M, Wente SR. Peering through the pore: Nuclear pore complex structure, assembly, and function. Dev Cell 2003;4:775-89
32. Husseman JW, Nochlin D, Vincent I. Mitotic activation: A convergent mechanism for a cohort of neurodegenerative diseases. Neurobiol Aging 2000;21:815-28
33. Becker EBE, Bonni A. Cell cycle regulation of neuronal apoptosis in development and disease. Prog Neurobiol 2004;72:1-25
34. Fifková E, Tonks M, Cullen-Dockstader K. Changes in the nuclear pore complexes of the dentate granule cells in aged rats. Exp Neurol 1987;95:755-62
35. Topple A, Smith G, Fifkova E, Cullen-Dockstader K. Nuclear pore complex frequency in CA1 pyramidal cells of the aging rat. Mech. Ageing Dev 1990;51:33-39
36. Garcia-Segura LM, LaFarga M, Berciano MT, et al. Distribution of nuclear pores and chromatin organization in neurons and glial cells of the rat cerebellar cortex. J Comp Neurol 1989;290:440-50
37. Xie C-X, Ozawa H, Yang Y-M, Kawata M. Immunohistochemical study of nucleoporin p62 in the hippocampus and hypothalamus of the rat brain. Neuroreport 2000;11:2965-67
38. Smyth PG, Berman SA, Bursztajn S. Markers of apoptosis: Methods for elucidating the mechanism of apoptotic cell death from the nervous system. Biotechniques 2002;32:648-65
39. Su JH, Kesslak JP, Head E, Cotman CW. Caspase-cleaved amyloid precursor protein and activated caspase-3 are co-localized in the granules of granulovacuolar degeneration in Alzheimer's disease and Down's syndrome brain. Acta Neuropathol 2002;104:1-6
40. Busser J, Geldmacher DS, Herrup K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J Neurosci 1998;18:2801-7
41. Yang Y, Mufson EJ, Herrup K. Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease. J Neurosci 2003;23:2557-63
42. DeKosky ST, Harbaugh RE, Schmitt FA, et al. Cortical biopsy in Alzheimer's disease: Diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Ann Neurol 1992;32:625-32
43. Tawa P, Hell K, Giroux A, et al. Catalytic activity of caspase-3 is required for its degradation: Stabilization of the active complex by synthetic inhibitors. Cell Death Differ 2004;11:439-47
44. Paschal BM, Gerace L. Identification of NTF2, a cytosolic factor for nuclear import that interacts with nuclear pore complex protein p62. J Cell Biol 1995;129:925-37
45. D'Andrea MR, Nagele RG, Wang H-Y, et al. Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology 2001;38:120-34
46. Su JH, Zhao M, Anderson AJ, et al. Activated caspase-3 expression in Alzheimer's and aged control brain: Correlation with Alzheimer pathology. Brain Res 2001;898:350-57
47. Rossiter JP, Anderson LL, Yang F, Cole GM. Caspase-cleaved actin (fractin) immunolabelling of Hirano bodies. Neuropathol Appl Neurobiol 2000;26:342-46
48. Stadelmann C, Deckwerth TL, Srinivasan A, et al. Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Am J Pathol 1999;155:1459-66
49. Zhu X, McShea A, Harris PLR, et al. Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease. J Neurosci Res 2004;75:698-703
50. Vincent I, Pai CI, Hallows JL. The cell cycle and human neurodegenerative disease. Prog Cell Cycle Res 2003;5:31-34
51. Chaillan-Huntington C, Braslavsky CV, Kuhlmann J, Stewart M. Dissecting the interactions between NTF2, RanGDP, and the nucleoporin XFXFG repeats. J Biol Chem 2000;275:5874-79
52. Quimby BB, Leung SW, Bayliss R, et al. Functional analysis of the hydrophobic patch on nuclear transport factor 2 involved in interactions with the nuclear pore in vivo. J Biol Chem 2001;276:38820-29